People & Business Resource Groups Leadership Team

Tinamarie Duff began her career at Bristol Myers Squibb more than 21 years ago. She has held a number of leadership roles during that time, and is currently the Global Lead for BMS’s DAWN (Differently-Abled Workplace Network) people and business resource group. DAWN’s purpose is to foster an environment and workplace culture that promotes the value of individuals with disabilities and their contributions to the company mission of helping patients prevail over serious diseases. DAWN has more than 2,300 members in 23 chapters across 5 continents.

Tinamarie is also a founding board member of All Wheels Up, a global organization that is conducting research and advocating for a wheelchair spot on commercial aircrafts, and serves as an advisor for the DisabilityIN NJ affiliate.

Tinamarie holds an M.B.A. degree and a B.A. degree from Dowling College on Long Island, NY.

Learn more about Differently-Abled Workplace Network (DAWN)

Updated: April 2021

Nataly Manjarrez-Orduño began her career at Bristol Myers Squibb in 2014 as a scientist in Translational Discovery. Since then, she has held roles of increasing responsibility in Drug Discovery and Translational Medicine and, up to June of 2021, was the scientific director of the Solid Tumor Late Development Translational Research Group.

Nataly has served as the BMS Global Lead for the Organization for Latino Achievement (OLA) People and Business Resource Group since 2021, where she can match her scientific background with her passion for the role that diversity and inclusion plays in delivering transformative medicine to our patients.

She received her Ph.D. and M.Sc. in molecular biomedicine from CINVESTAV, Mexico City, Mexico. She also received her B. Sc. in biological chemistry with high honors from the Universidad de Sonora in Mexico.

Learn more about Organization for Latino Achievement (OLA)

Updated: September 2021

Pat Krug joined Bristol Myers Squibb in 2018. Before becoming Global Lead of the Veterans Community Network (VCN), he was Senior District Business Manager in the US Oncology organization. He has been a member of the VCN leadership team since 2019, moving to VCN Lead in 2021 after serving as the Member Engagement Lead.  

Prior to joining BMS, Pat served as a Global Compliance Business Partner at AstraZeneca, holding numerous roles in commercial and compliance over a 24-year tenure. Pat also served with the US Army as medical services officer with the 4^th Infantry Division, leaving active duty in 1994.

Pat holds an MAHRM degree from Saint Francis University and a B.S. degree in biology from Virginia Military Institute.

Learn more about Veterans Community Network (VCN)

Updated: April 2021

Thalia Mingo began her career with Bristol Myers Squibb in 1998. As Global Lead for the Bristol Myers Squibb Network of Women (B-NOW), she is responsible for leading the global strategy and execution of gender-related diversity and inclusion priorities. Prior to her current role, Thalia completed a three-year tour of duty at the Global Capabilities Hub in Switzerland in the Worldwide Commercialization Team.

Thalia joined BMS as a Sales Representative, and was promoted into roles of increasing responsibility through the Commercial organization in Learning and Development, Marketing, and the Worldwide Commercial Operations Team. In 2013, she was responsible for successfully defining the strategy and execution of the new standards and operational approach for the creation and production of interactive sales content.

Immediately before joining BMS, Thalia worked for Anthem Blue Cross and Blue Shield, and prior to that, held roles in direct patient care systems.

Thalia holds a B.S. degree in biology and chemistry from South Carolina State University.

Learn more about Bristol Myers Squibb Network of Women (B-NOW)

Updated: April 2021

Paul Shay is a business executive with more than 15 years of experience in the pharmaceutical industry. He joined Bristol Myers Squibb in 2017 as the Head of Medical Strategy & Operations in R&D. Prior to his current role as Global Lead of the PRIDE Alliance PBRG, he led Strategy & Operations for additional functions in R&D, including Global Development Operations, Regulatory & Safety, Translational Medicine and Discovery. 

Paul began his pharmaceutical career at Johnson & Johnson, where he was the finance lead on a co-development program, helping to facilitate key investment decisions. He then worked for more than a decade at Pfizer in both the R&D and Commercial divisions. His experience there includes decision analytics, asset and portfolio strategy, governance design and management, annual planning process leadership, data analytics, and integration management.

As Global Lead of the PRIDE Alliance, Paul is focused on addressing LGBTQ+ health disparities, increasing workplace engagement and support of LGBTQ+ colleagues and allies, and bringing more diverse colleagues into the company.

Paul earned his M.B.A. degree from the Kellogg School of Management at Northwestern University and a B.S. degree in economics from the Massachusetts Institute of Technology.

Learn more about PRIDE Alliance

Updated: April 2021

Shamika Williams joined Bristol Myers Squibb in 2010 as a Human Resources Business Partner and currently serves as Global Lead of the Black Organization for Leadership & Development (BOLD).

Prior to joining Bristol Myers Squibb, Shamika worked for Thomson Reuters, BASF and Roche Diagnostics. From 2015-2019 she was a Founding Board member of Women of Color in Pharma (WOCIP), an organization formed to empower women of color in pharma and the life sciences to excel in their personal and professional development.

As a Global Enterprise Strategist and Operational Business Leader with 20 years of Human Resources  experience, Shamika possesses a natural passion for development, diversity, equity and inclusion, partnering with organizations to shape and execute their strategies with impact.

Shamika holds a B.S. degree in Business Administration from Bloomfield College, in Bloomfield, NJ.

Learn more about Black Organization for Leadership & Development (BOLD)

Updated: April 2021

Dr. Jing Yang has served as the Global Lead of Pan Asian Network since February 2019. She led a global team of internal colleagues and external partnerships to help the company advance its mission to transform the lives of patients through science by addressing disparities confronted by Asian-heritage colleagues and patients.

Jing joined Bristol Myers Squibb in 2007 and held a Research Fellow position prior to her current role. Serving as the Discovery Working Group Biology Co-Chair in cardiovascular research, Jing led the successful advancement of multiple innovative oral drug candidates through the pipeline. Jing received Bristol Myers Squibb’s Biology Leadership Award in 2016.

From 2005 to 2007, Jing was a Principal Scientist at the Stem Cell Internal Venture of Johnson & Johnson, where she led cardiac research of allogeneic stem cell platforms.

From 2001 to 2005, Jing was a Senior Scientist at Centocor Inc., where she led cardiovascular research of biologics and served as a member of the Cardiovascular Therapeutic Area Optimization Committee.

Jing is a member of American Heart Association council on Basic Cardiovascular Sciences and Arteriosclerosis, Thrombosis and Vascular Biology. In 2019, she served as a member of the Board of Directors of Life Sciences Pennsylvania and President of the Sino-American Pharmaceutical Professionals Association-Greater Philadelphia.  

Learn more about Pan Asian Network

Updated: April 2021

Adriana Zupa-Fernandez is a dedicated scientist and leader with more than 20 years of experience in the pharmaceutical sector. She has expertise across the industry and currently has assets in the clinic to potentially treat multiple autoimmune diseases. Her work includes the discovery of small molecule therapies and the management of clinical trials. Her deep understanding spans the Immunoscience, Immuno-Oncology, and Neuroscience spaces. Passionate and driven, she has proven herself in getting first-in-class assets from discovery to the clinic.

Before becoming the Global Lead of CLIMB, Adriana took that innovative approach to help develop BMS’ first trans-inclusive guidelines, created and led the Adoption Community Network, and successfully collaborated on inclusive and flexible parental leave policies for the workforce. In 2017, Adriana was chosen to represent Bristol Myers Squibb as a One Young World (OYW) delegate and was then selected in 2018 as the OYW team lead/Returning Ambassador for the company.

Adriana obtained her B.S. in biology from Drexel University, as well as an e.M.B.A. from Drexel University’s LeBow College of Business. She is an advocate, trailblazer, and author of multiple publications. 

Learn more about Cultivating Leadership and Innovation for Millennials and Beyond (CLIMB)

Updated: April 2021